@xconomy.com 4 months ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com 4 months ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More